Financhill
Back

Genmab AS 10K Form

Buy
60

GMAB
Genmab AS

Last Price:
$22.35
Seasonality Move:
16.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GMAB News And Ratings

See the #1 stock for the next 7 days that we like better than GMAB

GMAB Financial Statistics

Sales & Book Value

Annual Sales: $3.1B
Cash Flow: $353M
Price / Cash Flow: 13.33
Annual Sales: $8.06
Price / Book: 2.77

Profitability

EPS (TTM): 1.75130
Net Income (TTM): $1.1B
Gross Margin: $3B
Return on Equity: 23.85%
Return on Assets: 19.92%

Genmab AS Earnings Forecast

Key Genmab AS Financial Ratios

  • The Gross Profit Margin over the past 18 years for GMAB is 95.42%.
  • The Selling, General & Administrative Expenses for GMAB have been equal to 17.61% of Gross Profit Margin.
  • The Research & Development expenses have been 45.28% of Revenue.
  • The Interest Expense is 1.53% of Operating Income.
  • The Net Earning history of GMAB is 36.44% of Total Revenues.
  • Per Share Earnings over the last 23 years have been positive in 16 years.

Genmab AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: GMAB
Website: genmab.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.25
Quick Ratio: 5.24

Price-to-Earnings

Trailing P/E Ratio: 12.69
Forward P/E Ratio: 12.67

GMAB Technical Analysis vs Fundamental Analysis

Buy
60
Genmab AS (GMAB) is a Buy

Is Genmab AS a Buy or a Sell?

  • Genmab AS stock is rated a Buy
    The current Genmab AS [GMAB] share price is $22.34. The Score for GMAB is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.